Amundi STOXX Europe 600 Energy Screened UCITS ETF (OIGS)

https://www.youtube.com/shorts/O8JiNHcI3jI

And that doesn't include all derivaives eom

Thanks Silver! Been a long ride. Looks like we are taking off. Expect even new comers to get a successful investment from this as well. The rest of the year has so many more catalysts. What a ride.

Cheers!

Wait, another offering and more dilution? You know how I feel about dilution, but this time I fully support it. Securing strong cash reserves is exactly what a developmental biotech with great trial results needs. You provided a fantastic summary of our current position. Thanks, and go DFTX

The applicant’s claim that who drafted the SAP lacked experience in Alzheimer’s disease trial design and
analysis does not increase the credibility of the findings. The approach for analysing the data was
changed after the end of the study. The applicant openly admits problems with an

Bought 3 of these today.

Yes and note too that Anavex did not request scientific advise from the CHMP during the application process!!!

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3

IT IS DAMN IF IT GOES UP, DAMN IF IT GOES DOWN!which is it??? Let it flow freely . The harder the push, the harder the pullback. ROME WAS NOT BUILT IN ONE DAY. S

Doubled my position at low .01s. If I die, I die lol. Dust or Gold. Willing to double again at .0080s but that's it LOL.

CSAI on watch for possible squeeze play

Rumor was JPM hits 300….a distribution happens…just 50.00 for 60 days….but neither happened 

Great take and eloquently put, cheers to the future of this company and the sector as a whole! 🍻

No surprises to me, except that Anavex had applied for approval only for SIGMAR1 wild type patients.

The application relied on one pivotal trial that failed its primary objective. Claimed positive endpoint results were considered non-confirmatory because of the trial failure, lack of

I've followed Jeremy Grantham since the early 1990s. He's sometimes referred to as a perma-bear but he's simply a more conservative investor. He's also called the three most significant market downturns in the last 40 years. He's also calling this one; the AI bubble. Since I began taking this bubble

SCAM... proven SCAM... pump and dump winding down... maybe get back in at .0001-3 range and hold for a year +... maybe ...

Thx ...but its more confidence in the hedge funds backing UNCY .
They're in it to make as much $ as fast as possible ...are they at about 40% of ownership ?? will chk .
They will be all about licensing or out right sale ...although I expect them to wait to see if TDAPA is extended ou

All these share price predictions post IDE approval seem fairly low imo  . Let’s not forget IsoPet nearing profitability , India and other future international trials ?  And PrecisionGel licensing potential. Not a one trick pony . IDE approval should get the ball rolling 

pretty toxic

If I didn't like a ticker the last thing I would do is spend the entire f"n day here posting... Cover your short positions assholes...

Kobrea Confirms Copper-Gold Porphyry System at El Perdido – Core Still Untested, System Strengthening at Depth

Posted on behalf of Kobrea Copper Corp. - First drill campaign. Porphyry system confirmed. Most of the target still untested.

Kobrea's inaugural program at El

This ticker needs a GME F YOU...

when the audit comes out......it will be WORTH THE WAIT

CSAI about to make its move

$ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story — Execution, Recapitalization and Shareholder Value Are
June 25 2026

Following today’s announcement by Triller Group Inc. (Nasdaq: ILLR) regarding its SPCX-linked strategic treasury transaction, Wing-Fai Ng

Been 45 days since shares have been updated. Wonder how close this is to A.S. being maxed out ?